News - Press Releases
Check out the posts below to learn the latest updates on our progress
- July 6 2022EXUMA Biotech Announces Participation in the In Vivo Engineering of Therapeutic Cells SummitPRNewswire
- March 15 2022EXUMA Biotech to Present Preclinical Data from its Subcutaneous CAR-TaNK and In Vivo CAR Cell and Gene Therapy Programs at the American Association for Cancer Research Annual MeetingPRNewswire
- December 21 2021EXUMA Biotech Completes Series B2 to Advance Novel Cell & Gene TherapiesPRNewswire
- September 22 2021EXUMA Biotech to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare ConferencePRNewswire
- January 11 2021EXUMA Biotech Announces Collaboration with Moffitt Cancer Center for the Development of a Rapid-Point-Of-Care SC CAR-T ProgramPRNewswire
- November 11 2020EXUMA Biotech Presents Preclinical Data on Rapid Point-of-Care “rPOC” Subcutaneous CAR-T Platform at the SITC 35th Anniversary Annual Meeting & Pre-Conference
PR Newswire - October 19 2020Dr. Sid Kerkar Joins EXUMA Biotech as Vice President Oncology, R&D, Company Presents Data on HER2-Targeting CAR-T at AACR Tumor Immunology and Immunotherapy ConferencePR Newswire
- June 16 2020EXUMA Biotech Adds H. Michael Shepard to Scientific Advisory Board and Steven R. Frank to Board of DirectorsPR Newswire
- March 12 2020F1 Oncology Changes Name To EXUMA Biotech; Announces New Round Of Financing To Advance Cellular TherapiesPR Newswire
- June 18 2019EXUMA Biotechnology Expands Leadership Team with Appointment of Chief Medical Officer and Chief Financial OfficerPRNewswire